(CRBG) Corebridge Financial - Ratings and Ratios
Annuities, Life Insurance, Retirement Plans, Institutional Products
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.02% |
| Yield on Cost 5y | 7.20% |
| Yield CAGR 5y | 41.42% |
| Payout Consistency | 71.0% |
| Payout Ratio | 23.9% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 31.9% |
| Value at Risk 5%th | 52.0% |
| Relative Tail Risk | -1.08% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.05 |
| Alpha | -22.27 |
| CAGR/Max DD | 0.56 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.351 |
| Beta | 1.371 |
| Beta Downside | 1.766 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.88% |
| Mean DD | 8.53% |
| Median DD | 7.26% |
Description: CRBG Corebridge Financial October 16, 2025
Corebridge Financial, Inc. (NYSE: CRBG) delivers retirement and insurance solutions across four segments: Individual Retirement (fixed, indexed, and variable annuities), Group Retirement (in-plan recordkeeping, flexible annuities, and advisory services), Life Insurance (term, whole, indexed universal, and guaranteed universal life), and Institutional Markets (stable-value wraps, pension-risk-transfer annuities, BOLI, and private-placement products). The firm, formerly SAFG Retirement Services, was incorporated in 1998 and is based in Houston, Texas.
Key operating metrics from the most recent FY 2023 filing show total revenue of approximately $2.1 billion, a net income of $210 million, and a combined ratio of 92.5% in the annuity business-indicating modest underwriting profitability. The segment most sensitive to macro-economic conditions is Individual Retirement, where rising interest rates have lifted the yields on fixed-index annuities but also increased the cost of guarantees, while longevity risk remains a primary driver for Life Insurance pricing. Institutional demand for stable-value wraps and pension-risk-transfer solutions has been buoyed by corporate cash-rich balance sheets seeking higher yields in a low-coupon environment.
For a deeper, data-driven view of CRBG’s valuation dynamics and scenario analysis, you may find the research tools on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (991.0m TTM) > 0 and > 6% of Revenue (6% = 172.5m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA -0.16pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 1939 % (prev 2579 %; Δ -640.7pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.00 (>3.0%) and CFO 1.62b > Net Income 991.0m (YES >=105%, WARN >=100%) |
| Net Debt (10.70b) to EBITDA (2.42b) ratio: 4.42 <= 3.0 (WARN <= 3.5) |
| Current Ratio 6.96 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (540.6m) change vs 12m ago -7.92% (target <= -2.0% for YES) |
| Gross Margin 80.35% (prev 78.73%; Δ 1.62pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 0.71% (prev 0.64%; Δ 0.06pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.50 (EBITDA TTM 2.42b / Interest Expense TTM 565.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.08
| (A) 0.14 = (Total Current Assets 65.09b - Total Current Liabilities 9.36b) / Total Assets 411.29b |
| (B) 0.04 = Retained Earnings (Balance) 17.68b / Total Assets 411.29b |
| (C) 0.00 = EBIT TTM 1.98b / Avg Total Assets 405.36b |
| (D) 0.02 = Book Value of Equity 8.66b / Total Liabilities 396.97b |
| Total Rating: 1.08 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 43.75
| 1. Piotroski 3.50pt |
| 2. FCF Yield -4.10% |
| 3. FCF Margin 56.31% |
| 4. Debt/Equity 0.81 |
| 5. Debt/Ebitda 4.42 |
| 6. ROIC - WACC (= -5.59)% |
| 7. RoE 8.04% |
| 8. Rev. Trend -25.78% |
| 9. EPS Trend -32.59% |
What is the price of CRBG shares?
Over the past week, the price has changed by +7.14%, over one month by -7.97%, over three months by -13.95% and over the past year by -4.33%.
Is CRBG a buy, sell or hold?
- Strong Buy: 6
- Buy: 5
- Hold: 2
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the CRBG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 38.8 | 31.1% |
| Analysts Target Price | 38.8 | 31.1% |
| ValueRay Target Price | 31.5 | 6.3% |
CRBG Fundamental Data Overview November 20, 2025
P/E Trailing = 18.7823
P/E Forward = 5.322
P/S = 0.7595
P/B = 1.0365
Beta = 0.916
Revenue TTM = 2.88b USD
EBIT TTM = 1.98b USD
EBITDA TTM = 2.42b USD
Long Term Debt = 11.02b USD (from longTermDebt, last quarter)
Short Term Debt = 9.36b USD (from shortTermDebt, last quarter)
Debt = 11.02b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.70b USD (from netDebt column, last quarter)
Enterprise Value = -39.53b USD (13.93b + Debt 11.02b - CCE 64.47b)
Interest Coverage Ratio = 3.50 (Ebit TTM 1.98b / Interest Expense TTM 565.0m)
FCF Yield = -4.10% (FCF TTM 1.62b / Enterprise Value -39.53b)
FCF Margin = 56.31% (FCF TTM 1.62b / Revenue TTM 2.88b)
Net Margin = 34.47% (Net Income TTM 991.0m / Revenue TTM 2.88b)
Gross Margin = 80.35% ((Revenue TTM 2.88b - Cost of Revenue TTM 565.0m) / Revenue TTM)
Gross Margin QoQ = 81.35% (prev 81.41%)
Tobins Q-Ratio = -0.10 (set to none) (Enterprise Value -39.53b / Total Assets 411.29b)
Interest Expense / Debt = 1.23% (Interest Expense 135.0m / Debt 11.02b)
Taxrate = 426.2% (out of range, set to none) (-179.0m / -42.0m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 6.96 (Total Current Assets 65.09b / Total Current Liabilities 9.36b)
Debt / Equity = 0.81 (Debt 11.02b / totalStockholderEquity, last quarter 13.54b)
Debt / EBITDA = 4.42 (Net Debt 10.70b / EBITDA 2.42b)
Debt / FCF = 6.61 (Net Debt 10.70b / FCF TTM 1.62b)
Total Stockholder Equity = 12.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.24% (Net Income 991.0m / Total Assets 411.29b)
RoE = 8.04% (Net Income TTM 991.0m / Total Stockholder Equity 12.32b)
RoCE = 8.48% (EBIT 1.98b / Capital Employed (Equity 12.32b + L.T.Debt 11.02b))
RoIC = 0.59% (EBIT 1.98b / (Assets 411.29b - Curr.Liab 9.36b - Cash 64.47b))
WACC = 6.18% (E(13.93b)/V(24.94b) * Re(11.07%) + (debt cost/tax rate unavailable))
Discount Rate = 11.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -7.59%
[DCF Debug] Terminal Value 69.39% ; FCFE base≈1.85b ; Y1≈2.00b ; Y5≈2.45b
Fair Price DCF = 52.88 (DCF Value 26.67b / Shares Outstanding 504.4m; 5y FCF grow 8.53% → 3.0% )
EPS Correlation: -32.59 | EPS CAGR: -42.85% | SUE: -4.0 | # QB: 0
Revenue Correlation: -25.78 | Revenue CAGR: -45.28% | SUE: -0.68 | # QB: 0
Additional Sources for CRBG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle